Loading...

Diversified Vaccine And Cancer Therapy Platform Will Transform Long Term Earnings Potential

Published
12 Dec 25
Views
1
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-85.3%
7D
-16.3%

Author's Valuation

US$1497.6% undervalued intrinsic discount

AnalystHighTarget Fair Value